Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control [Phase 2]

View source ↗

Summary

Phase 2 long-term safety and efficacy follow-up study of SMUP-IA-01 versus active control for knee osteoarthritis; current status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SMUP-IA-01

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Knee Osteoarthritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING